Overview
- 8 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-04-14.
At a glance
Inspections
8
Form 483s
7
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 7 Apr 2025 – 14 Apr 2025 | Human Drugs | WL | View 483 → |
| 23 Jan 2020 – 29 Jan 2020 | Human Drugs | 483 | View 483 → |
| 5 Jan 2017 – 11 Jan 2017 | Human Drugs | 483 | View 483 → |
| 5 Mar 2015 – 27 Mar 2015 | Human Drugs | 483 | View 483 → |
| 30 Nov 2011 | Not recorded | 483 | On file |
| 17 Dec 2010 | Not recorded | 483 | On file |
| 29 Jul 2008 | Not recorded | 483 | On file |
| 14 Nov 2003 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
14 Apr 2025
21 CFR 211.110(a)
Control procedures to monitor and validate performance
Cited by Anney Lin, Nathan E Hellman
14 Apr 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Anney Lin, Nathan E Hellman
14 Apr 2025
21 CFR 211.84(d)(1)
Identity Testing of Each Component
Cited by Anney Lin, Nathan E Hellman
Investigators
FDA investigators tied to this site in the record.
Kevin P Foley2 insp.
Anney Lin1 insp.
Nathan E Hellman1 insp.
Scott N Lim1 insp.
David Eng1 insp.
James C Lee1 insp.
Lucila B Nwatu1 insp.
Stephanie A Slater1 insp.
Daniel J Roberts1 insp.
Mei-Chiung J Huang1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.180(e)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.101(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.125(f) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(f) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(b)(3) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.89 | Cited across public-safe Form 483 observations | 2x |
| FDCA 601(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(1) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Columbia Cosmetics Manufacturing, Inc.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat